Skip to main content

Advertisement

Log in

Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Although atypical meningioma recurs frequently in spite of total resection and/or radiotherapy, no consensus on optimal adjuvant management was found. However, several retrospective studies analysed the additional effect of adjuvant radiotherapy in atypical meningioma with inconsistent results. Therefrom, the purpose of this study was to evaluate prognostic factors influencing the recurrence/progression and progression-free survival (PFS) rates of atypical meningioma, particularly focused on the role of postoperative adjuvant radiotherapy. Between February 2001 and March 2015, 161 atypical meningioma resections were performed in our Department of Neurosurgery, of which, 128 cases underwent surgical treatment alone and 33 cases underwent surgery and radiotherapy. Kaplan–Meier analysis was used to provide median point estimates and PFS rates. The Cox-regression model was used in the univariate and multivariate analysis to identify significant factors associated with treatment. The extent of resection (Simpson grade I and II) significantly influenced the risk of recurrence (hazard ratio = 1.8, CI (95%) 1.3–2.6, p-value = 0.0004). There was no significant benefit for progression-free survival after adjuvant radiotherapy (hazard ratio = 1.48, CI (95%) 0.76–2.86, p-value = 0.22). Additionally, meningioma located at the anterior and posterior fossa showed a significantly longer PFS compared to other locations (p-value = 0.03). Adjuvant postoperative radiotherapy had no significant impact on recurrence/progression rate or PFS. The extent of resection according to Simpson grade remains the most important prognostic factor associated with lower recurrence/progression rates and longer PFS in patients with atypical meningioma. The location of the tumours at the anterior or posterior fossa was an independent factor associated with improved PFS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Adeberg S, Hartmann C, Welzel T, Rieken S, Habermehl D, von Deimling A et al (2011) Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas-clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. Int J Radiat Oncol Biol Phys 83:859–864. doi:10.1016/j.ijrobp.2011.08.010

    Article  PubMed  Google Scholar 

  2. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL et al (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64:56–60. doi:10.1227/01.NEU.0000330399.55586.63

    Article  PubMed  Google Scholar 

  3. Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD et al (2014) Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol 16:1547–1553. doi:10.1093/neuonc/nou098

    Article  PubMed  PubMed Central  Google Scholar 

  4. Andric M, Dixit S, Dubey A, Jessup P, Hunn A (2012) Atypical meningiomas—a case series. Clin Neurol Neurosurg 114:699–702. doi:10.1016/j.clineuro.2011.11.023

    Article  PubMed  Google Scholar 

  5. Bagshaw HP, Burt LM, Jensen RL, Suneja G, Palmer CA, Couldwell WT et al (2016) Adjuvant radiotherapy for atypical meningiomas. J Neurosurg. doi:10.3171/2016.5.JNS152809

    PubMed  Google Scholar 

  6. Cao X, Hao S, Wu Z, Wang L, Jia G, Zhang L et al (2015) Treatment response and prognosis after recurrence of atypical meningiomas. World Neurosurg 84:1014–1019. doi:10.1016/j.wneu.2015.05.032

    Article  PubMed  Google Scholar 

  7. Champeaux C, Dunn L (2016) World Health Organization grade II meningiomas. Acta Neurochir 158:921–929. doi:10.1007/s00701-016-2771-y

    Article  PubMed  Google Scholar 

  8. Champeaux C J V (2016) World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment. Neurochirurgie 62:203–208

    Article  CAS  PubMed  Google Scholar 

  9. Clark VE, Erson-omay EZ, Serin A, Yin J, Cotney J, Avşar T et al (2016) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077–1080. doi:10.1126/science.1233009.Genomic

    Article  Google Scholar 

  10. Cohen-inbar O, Lee C, Schlesinger D, Xu Z, Sheehan JP (2016) Long-term results of stereotactic radiosurgery for skull base meningiomas. Neurosurgery 79:58–68. doi:10.1227/NEU.0000000000001045

    Article  PubMed  Google Scholar 

  11. Cohen-inbar O, Tata A, Moosa S, Lee C, Sheehan JP (2017) Stereotactic radiosurgery in the treatment of parasellar meningiomas: long-term volumetric evaluation. J Neurosurg. doi:10.3171/2016.11.JNS161402

    Google Scholar 

  12. Durand A, Labrousse F, Jouvet A, Bauchet L, Kalamaridès M, Menei P, Deruty R, Moreau JJ, Fèvre-Montange M, Guyotat J (2009) WHO grade II and III meningiomas: a study of prognostic factors. J Neurooncol 95:367–375

    Article  PubMed  Google Scholar 

  13. Dziuk TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, Lu H, Carpenter LS Chiu JK (1998) Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy. J Neurooncol 37:177–188

    Article  CAS  PubMed  Google Scholar 

  14. Endo T, Narisawa A, Ali HSM, Murakami K, Watanabe T, Watanabe M et al (2016) A study of prognostic factors in 45 cases of atypical meningioma. Acta Neurochir 158:1661–1667. doi:10.1007/s00701-016-2900-7

    Article  PubMed  Google Scholar 

  15. Hammouche S, Clark S, Wong AH, Eldridge P FJ (2014) Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir 156:1475–1481

    Article  PubMed  Google Scholar 

  16. Hasan S, Young M, Albert T, Shah AH, Okoye C, Bregy A et al (2015) The role of adjuvant radiotherapy after gross total resection of atypical meningiomas. World Neurosurg 83:808–815. doi:10.1016/j.wneu.2014.12.037

    Article  PubMed  Google Scholar 

  17. Heynckes S, Gaebelein A, Haaker G, Grauvogel J, Franco P, Mader I et al (2017) Expression differences of programmed death ligand 1 in de-novo and recurrent glioblastoma multiforme. Oncotarget 1:1–8

    Google Scholar 

  18. Iley KRR (2008) Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. Neurosurg Focus 24:1–8. doi:10.3171/FOC/2008/24/5/E3

    Google Scholar 

  19. Jenkinson MD, Javadpour M, Haylock BJ, Young B, Gillard H, Vinten J et al (2015) The ROAM/EORTC-1308 trial: radiation versus observation following surgical resection of atypical meningioma: study protocol for a randomised controlled trial. Trials 16:519. doi:10.1186/s13063-015-1040-3

    Article  PubMed  PubMed Central  Google Scholar 

  20. Jenkinson MD, Waqar M, Farah JO, Farrell M, Barbagallo GM V, McManus R et al (2016) Early adjuvant radiotherapy in the treatment of atypical meningioma. J Clin Neurosci 28:87–92. doi:10.1016/j.jocn.2015.09.021

    Article  PubMed  Google Scholar 

  21. Jo K, Park HJ, Nam DH, Lee J Il, Kong DS, Park K et al (2010) Treatment of atypical meningioma. J Clin Neurosci 17:1362–1366. doi:10.1016/j.jocn.2010.03.036

    Article  PubMed  Google Scholar 

  22. Kane AJ, Sughrue ME, Rutkowski MJ, Shangari G, Fang S (2011) Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer 117:1272–1278. doi:10.1002/cncr.25591

    Article  PubMed  Google Scholar 

  23. Kaur G, Sayegh ET, Larson A, Bloch O, Madden M, Sun MZ et al (2014) Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review. Neuro Oncol 16:628–636. doi:10.1093/neuonc/nou025

    Article  PubMed  PubMed Central  Google Scholar 

  24. King G, Stuart EA (2011) MatchIt: nonparametric preprocessing for parametric causal inference. J Stat Softw 42:1–28

    Google Scholar 

  25. Lee KD, DePowell JJ, Air EL, Dwivedi AK, Kendler A, McPherson CM (2013) Atypical meningiomas: is postoperative radiotherapy indicated? Neurosurg Focus 35:E15. doi:10.3171/2013.9.FOCUS13325

    Article  PubMed  Google Scholar 

  26. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. doi:10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  27. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW KP (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109

    Article  PubMed  PubMed Central  Google Scholar 

  28. Modha A GP (2005) Diagnosis and treatment of atypical and anaplastic meningiomas: a review. Neurosurgery 57:538–550

    Article  PubMed  Google Scholar 

  29. Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16(Suppl 4):iv1–iv63. doi:10.1093/neuonc/nou223

    Article  PubMed  PubMed Central  Google Scholar 

  30. Park HJ, Kang HC, Kim IH, Park SH, Kim DG, Park CK et al (2013) The role of adjuvant radiotherapy in atypical meningioma. J Neurooncol 115:241–247. doi:10.1007/s11060-013-1219-y

    Article  CAS  PubMed  Google Scholar 

  31. Pisćević I, Villa A, Milićević M, Ilić R, Nikitović M, Cavallo LM et al (2015) The influence of adjuvant radiotherapy in atypical and anaplastic meningiomas: a series of 88 patients in a single institution. World Neurosurg 83:987–995. doi:10.1016/j.wneu.2015.02.021

    Article  PubMed  Google Scholar 

  32. Refaat T, Gentile M, Sachdev S, Dalal P, Butala A, Gutiontov S, Helenowksi I, Lee P, Sathiaseelan V, Bloch O, Chandler J (2017) Gamma Knife stereotactic radiosurgery for grade 2 meningiomas. J Neurol Surg 78:288–294

    Article  Google Scholar 

  33. Saraf S, McCarthy BJ, Villano JL (2011) Update on meningiomas. Oncologist 16:1604–1613. doi:10.1634/theoncologist.2011-0193

    Article  PubMed  PubMed Central  Google Scholar 

  34. Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Vranic A, Popovic M, Cör A, Prestor B, Pizem J (2010) Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primery atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 67:1124–1132

    Article  PubMed  Google Scholar 

  36. Zaher A, Abdelbari Mattar M, Zayed DH, Ellatif RA, Ashamallah SA (2013) Atypical meningioma: a study of prognostic factors. World Neurosurg 80:549–553. doi:10.1016/j.wneu.2013.07.001

    Article  PubMed  Google Scholar 

  37. Zhao P, Hu M, Zhao M, Ren X (2015) Prognostic factors for patients with atypical or malignant meningiomas treated at a single center. Neurosurg Rev 38:101–107. doi:10.1007/s10143-014-0558-2

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Waseem Masalha.

Ethics declarations

Conflict of interest

Authors declare no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 221 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Masalha, W., Heiland, D.H., Franco, P. et al. Atypical meningioma: progression-free survival in 161 cases treated at our institution with surgery versus surgery and radiotherapy. J Neurooncol 136, 147–154 (2018). https://doi.org/10.1007/s11060-017-2634-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2634-2

Keywords

Navigation